Riskpilot← Back to searchSign inGet full accessFARMASIKOMPETANSE AS
ASActiveOrg 987623098Bjørn Wirkolas Vei 15, 9510 AltaOther human health activities n.e.c. · NACE 8699Est. 20040 employees
Revenue 2025
NOK 1,5M
+12% vs 2024
EBITDA margin
27.1%
+28% vs 2024
Equity ratio
17.8%
Financial strength
Net profit 2025
NOK 308K
+28% vs 2024
| Revenue | NOK 1,5M | +12% |
| EBITDA | NOK 394K | +28% |
| Net profit | NOK 308K | +28% |
| Total assets | NOK 618K | +23% |
| Equity | NOK 110K | +8% |
| Employees | 0 | — |
Legal name
FARMASIKOMPETANSE AS
Org number
987623098
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
23. desember 2004
Share capital
NOK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Utleie av personell, undervisning samt rådgivning og tjenester innenfor helse.
Address
Bjørn Wirkolas Vei 15, 9510 Alta
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 851 | 1 362 | 1 457 | 1 298 | 1 454 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 624 | 398 | 488 | 308 | 394 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 624 | 398 | 488 | 308 | 394 |
| Net financials | 0 | −0 | 0 | −0 | 1 |
| Profit before tax | 624 | 398 | 489 | 308 | 395 |
| Tax | 137 | 88 | 107 | 68 | 87 |
| Net profit | 486 | 311 | 381 | 240 | 308 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 859 | 625 | 757 | 503 | 618 |
| Equity | 100 | 101 | 102 | 102 | 110 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 759 | 525 | 655 | 401 | 508 |
| Total debt | 759 | 525 | 655 | 401 | 508 |
EBITDA margin
27.1%
This company
15.8%
Market median
+72% vs market
20212025
Equity ratio
17.8%
This company
38.2%
Market median
-53% vs market
20212025
Return on equity
279.9%
This company
18.4%
Market median
+1421% vs market
20212025
Net profit margin
21.2%
This company
8.1%
Market median
+162% vs market
20212025
Asset turnover
2.35×
This company
1.12×
Market median
+110% vs market
20212025
Debt / equity
4.62×
This company
0.62×
Market median
-645% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Former (1) | ||
| Chairman | 2004 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 40% | 40% | 2022 | |
| Company | 40% | 40% | 2024 | |
| Individual | 20% | 20% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FARMASIKOMPETANSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Paul Tore Nielsen | Chairman | 0 companies |
| Christine Øygarden Zountourides | Board of Directors | 0 companies |
| Hege Hillestad | Chairman | 0 companies |